This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, J.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, J.-H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2004, p. 4926-4928, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4926-4928.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin

Jae-Hoon Song,1,2* Keiichi Hiramatsu,3 Ji Yoeun Suh,2 Kwan Soo Ko,2 Teruyo Ito,3 Maria Kapi,3 Sungmin Kiem,1 Yeon-Sook Kim,4 Won Sup Oh,1 Kyong Ran Peck,1 Nam Yong Lee,5 and and the Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group{dagger}

Division of Infectious Diseases,1 Department of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,5 Asian-Pacific Research Foundation for Infectious Diseases (ARFID), Seoul,2 Chungnam National University Hospital, Daejon, South Korea,4 Department of Bacteriology, Juntendo University, Tokyo, Japan3

Received 10 June 2004/ Returned for modification 12 August 2004/ Accepted 19 August 2004

To investigate the prevalence of Staphylococcus aureus with reduced susceptibility to vancomycin among methicillin-resistant S. aureus (MRSA) strains in Asian countries, a total of 1,357 clinical isolates of MRSA collected from 12 Asian countries were screened by using brain heart infusion agar plates containing 4 mg of vancomycin per liter. The presence of strains that were heterointermediately resistant to vancomycin (hVISA) was confirmed by population analysis. Of 347 (25.6%) MRSA isolates that grew on the screening agar plates, 58 isolates (4.3%) were hVISA. hVISA strains were found in India, South Korea, Japan, the Philippines, Singapore, Thailand, and Vietnam. However, neither vancomycin-intermediate S. aureus nor vancomycin-resistant S. aureus isolates were found among MRSA isolates from Asian countries in this survey.

* Corresponding author. Mailing address: Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University, Asian-Pacific Research Foundation for Infectious Diseases (ARFID), 50 Il-won dong, Kangnam-ku, Seoul 135-710, South Korea. Phone: 82-2-3410-0320. Fax: 82-2-3410-0328. E-mail: jhsong{at}smc.samsung.co.kr

{dagger} Contributing members of the ANSORP Study Group are listed in Acknowledgments.

Antimicrobial Agents and Chemotherapy, December 2004, p. 4926-4928, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4926-4928.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Florescu, I., Beuran, M., Dimov, R., Razbadauskas, A., Bochan, M., Fichev, G., Dukart, G., Babinchak, T., Cooper, C. A., Ellis-Grosse, E. J., Dartois, N., Gandjini, H., on behalf of the 307 Study Group, (2008). Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother 62: i17-i28 [Abstract] [Full Text]  
  • Kohno, S., Yamaguchi, K., Aikawa, N., Sumiyama, Y., Odagiri, S., Aoki, N., Niki, Y., Watanabe, S., Furue, M., Ito, T., Croos-Dabrera, R., Tack, K. J. (2007). Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. J Antimicrob Chemother 60: 1361-1369 [Abstract] [Full Text]  
  • Park, H. S., Yoon, Y. M., Jung, S. J., Kim, C. M., Kim, J. M., Kwak, J.-H. (2007). Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. J Antimicrob Chemother 60: 568-574 [Abstract] [Full Text]  
  • Wang, G., Hindler, J. F., Ward, K. W., Bruckner, D. A. (2006). Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period. J. Clin. Microbiol. 44: 3883-3886 [Abstract] [Full Text]  
  • Ip, M., Yung, R. W. H., Ng, T. K., Luk, W. K., Tse, C., Hung, P., Enright, M., Lyon, D. J. (2005). Contemporary Methicillin-Resistant Staphylococcus aureus Clones in Hong Kong. J. Clin. Microbiol. 43: 5069-5073 [Abstract] [Full Text]  
  • Ishizawa, K., Suzuki, T., Yamaya, M., Jia, Y. X., Kobayashi, S., Ida, S., Kubo, H., Sekizawa, K., Sasaki, H. (2005). Erythromycin increases bactericidal activity of surface liquid in human airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L565-L573 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»